OncoCyte
In Brief This Week: 23andMe, Oncocyte, MDxHealth, Ginkgo Bioworks, GC Genome, More
News items for the week of Nov. 6, 2023
Oncocyte VitaGraft Kidney Transplant Test Receives CMS Coverage
Palmetto issued a positive coverage decision for VitaGraft Kidney under the same LCD covering CareDx's HeartCare transplant surveillance service.
In Brief This Week: MiRxes, Oncocyte, OpGen, Biodesix, Element Biosciences, More
News items for the week of Aug. 7, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
The split will reduce the number of outstanding shares of Oncocyte's common stock to approximately 8.2 million, subject to potential adjustments.
People in the News at Tempus, Oncocyte, Guardant Health, National Academy of Sciences, 23andMe, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of May 8, 2023.
Apr 13, 2023
Oncocyte Lays off 20 Percent of Workforce
Apr 14, 2022